My research activities involve initiating clinical trials in renal cancer and prostate cancer, and technology assessment as applied to the introduction of minimally invasive surgery.
Modulating ATP Binding Cassette (ABC) Transporters in Papillary Renal Cell Carcinoma Type 2 Enhances its Response to Targeted Molecular Therapy.
Mol Oncol. 2018 Jun 13;:
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Nat Commun. 2018 Jun 11;9(1):2256
Nat Genet. 2018 Jun 11;:
Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.
BMC Health Serv Res. 2018 Jun 08;18(1):430
Prostate Cancer Prostatic Dis. 2018 Jun 06;:
JAMA Intern Med. 2018 May 01;178(5):727-728
J Urol. 2018 May 11;:
Transl Androl Urol. 2018 Apr;7(2):243-255
Curr Opin Urol. 2018 Apr 26;:
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Assistant Professor, Departments of Surgery and Oncology, University of Toronto
Staff Surgeon, Surgical Oncology, Division of Urology, University Health Network